Obagi-C C-Rx System Normal-Dry Skin Intervention

SPL

Last synced from FDA National Drug Code directory (United States) on June 3, 2026

Identification

ManufacturerObagi Cosmeceuticals LLC

CountryUS (United States)

ATC code—

Dispensing—

ReimbursedNo

SourceFDA National Drug Code directory (United States)

Last synced6/3/2026

Packs · 1

ndc11
6203291601
1 KIT in 1 CARTON (62032-916-01) * 1 TUBE in 1 CARTON (62032-140-09) / 85 g in 1 TUBE * 177 mL in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC (62032-105-36) * 1 BOTTLE, GLASS in 1 CARTON (62032-106-10) / 30 mL in 1 BOTTLE, GLASS

Annotations

DailyMed SPL labels

1 version tracked

Raw payload (JSON)

{
  "route": null,
  "spl_meta": {
    "321e58d0-9964-4da9-af6b-66ba81b60cf7": {
      "match": "brand_token",
      "title": "OBAGI-C FX SYSTEM NORMAL-OILY SKIN BRIGHTENING SYSTEM WITH ARBUTIN (HOMOSALATE, OCTISALATE, ZINC OXIDE) KIT [OBAGI COSMECEUTICALS LLC]",
      "spl_version": "3",
      "published_date": "2026-01-28"
    }
  },
  "productid": "62032-916_8562c1e2-2e0a-4aba-911a-dd89f1c59b4a",
  "productndc": "62032-916",
  "dosage_form": "KIT",
  "dea_schedule": null,
  "product_type": "HUMAN OTC DRUG",
  "substance_name": null,
  "proprietary_name": "Obagi-C C-Rx System Normal-Dry Skin Intervention",
  "active_ingred_unit": null,
  "application_number": null,
  "marketing_category": "UNAPPROVED DRUG OTHER",
  "nonproprietary_name": "HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE",
  "start_marketing_date": "20191202",
  "active_numerator_strength": null
}

Access this data programmatically

Query Obagi-C C-Rx System Normal-Dry Skin Intervention and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs